While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a...
Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
Dr Matera discusses common concerns and questions patients with chronic kidney disease ask their physicians, as well as the importance of collaboration between nephrologists and primary care physicians in...
Juan C. Celedón, MD, DrPh, from the University of Pittsburgh, answers our questions about his research on omics in childhood asthma—a topic he has also spoken about at the Celebration of Pediatric...
Results of a new study show that women experience gender-specific concerns due to their subcutaneous implantable cardioverter-defibrillators. In this Q&A, Willeke van der Stuijt, MD, highlights those...
Christopher Still, DO, director of Geisinger Obesity Institute, shares common questions he receives from patients about weight loss, as well as the impact of fad diets, unregulated supplements, and online...
Kevin Hackshaw, MD, answers our questions about his study that identified a blood test as a potential biomarker for the diagnosis of fibromyalgia and other rheumatic disorders.
A recent study led by Kerry Flannagan, PhD, examined how opioid use may result in pregnancy loss and lower changes of conception. Dr Flannagan answered our questions about her team’s study.
Consultant360 spoke with lead author Greg Kinney, PhD, about his study, which found that cannabis use may be associated with an increased risk for diabetic ketoacidosis in patients with type 1 diabetes. ...
A recent study compared the use of mental health and physical health services among mothers of children with multiple sclerosis (MS) and those of children without MS. Lead researcher Ruth Ann Marrie, MD,...
